The European Parliament’s Reports Include Several ESMO Asks and Materially Strengthen the European Commission Proposals Under the ‘Health Package’

Proposed changes to the EU in vitro diagnostic medical devices (IVDR) legislation, and the EU Biotech Act I, help address key ESMO concerns on fragmented procedures, lower-risk testing, central laboratories and multinational oncology studies, ensuring more equitable access to innovative oncology treatment for all patients with cancer

Source